On November 19, 2015, the US Food and Drug Administration (FDA) approved the "all fish" growth hormone (gh) transgenic Atlantic salmon for public consumption, which is significant as this species is the first genetically engineered livestock approved for human consumption and is considered as breakthrough of transgenic livestock breeding research and livestock industrialization. The US FDA made this landmark decision after 20 years rigorous bio-safety assessment of the transgenic salmon. This development reveals that all the management decisions in pursuing innovation in industry should follow the scientific method and be based on objective facts. It also reveals that basic research is one of the factors involved in industrial innovation. Both the scientific research behind the creation of this transgenic product and the active participation of the business sector have become increasingly important components for promoting the development of new high-level technologies and innovative industries. Furthermore, it is an urgent demand to strategically make the regulation and standardize its industrialization guidelines for agricultural genetically modified organisms.